Page 3 - Pharmaceuticals
Indian pharmaceutical companies spread business to avoid regulatory ire
Increased USFDA import alerts could be reason for finding alternative sites
 "Indian pharmaceutical companies spread business to avoid regulatory ire")
FDA observations on Telangana plant a fresh headache for Aurobindo Pharma
The Telangana unit in question is an important one contributing about a fifth to US revenues
 "FDA observations on Telangana plant a fresh headache for Aurobindo Pharma")
Eywa aims to make mark in US market with own label, skip generic trend
The company, which is backed by Eight Roads Ventures, has got approval for 20 of its 36 products in the US and the EU
 "Eywa aims to make mark in US market with own label, skip generic trend")
Purdue Pharma files for bankruptcy in bid to settle opioid crisis cases
Pharmaceutical giant is facing thousands of lawsuits blaming its prescription painkiller OxyContin for plunging millions of Americans into addiction.
 "Purdue Pharma files for bankruptcy in bid to settle opioid crisis cases")
Domestic drug portfolio a key driver of Ajanta Pharma's growth prospects
Industry beating growth along with high US sales are keeping analysts positive on the company's earnings prospects
 "Domestic drug portfolio a key driver of Ajanta Pharma's growth prospects")
Domestic pharma companies eye robust growth from US market in FY20
While companies continue to face regulatory pressure leading to higher costs, they see an uptick from the launch of differentiated and high-margin products
 "Domestic pharma companies eye robust growth from US market in FY20")
Investors find new formula in pharma as focus shifts from US generics
Pharma manufacturing systems with specific themes, stable margins have long term commercial potential
 "Investors find new formula in pharma as focus shifts from US generics")
Bristol-Myers to buy Celgene for $74 billion in largest biopharma deal
Some analysts, including Baird Equity's Brian Skorney, said it raised the possibility of a new era of big drug deals
 "Bristol-Myers to buy Celgene for $74 billion in largest biopharma deal")
MNC drug majors outshine Indian peers, draw investors' attention
To stand out, Indian companies are investing more in research and development
 "MNC drug majors outshine Indian peers, draw investors' attention")
Medical representatives offering cash to boost sales, says chemists body
Industry sources point out that cash offers to distributors is a common practice
 "Medical representatives offering cash to boost sales, says chemists body")
Zydus Cadila's Baddi facility receives US FDA nod
The company has also received US FDA approval for anti-depressant drug, mirtazapine
 "Zydus Cadila's Baddi facility receives US FDA nod")
Indian big pharma R&D spend grows even as US growth slows
This has come in at a time when the revenue growth has slowed down
 "Indian big pharma R&D spend grows even as US growth slows")
Sluggish growth in US, demonetisation & GST slow down pharma market
Aggregate revenues of 21 leading firms grew by 7.4% in FY2017 compared to 10.1% in FY2016, says ICRA
US FDA approves Natco Pharma's anti-cancer drug azacitidine
The approved product is a generic version of Vidaza, which recorded annual sales of $ 188 mn
 "US FDA approves Natco Pharma's anti-cancer drug azacitidine")
Worldwide drug sales to hit $ 1.06 trillion in 2022: Study
Pricing pressure to cause drug sales forecasts to fall for first time in 10 years, says Evaluate
 "Worldwide drug sales to hit $ 1.06 trillion in 2022: Study")
Glenmark receives US FDA nod for anti-inflammatory drug indomethacin
Indomethacin extended-release capsule (75 mg) is generic version of Iroko Pharmaceuticals' Indocin
 "Glenmark receives US FDA nod for anti-inflammatory drug indomethacin")
Sun Pharma and NIV join forces to fight zika, chikungunya & dengue
National Institute of Virology to receive Sun Pharma's drug molecules for testing against 3 diseases
 "Sun Pharma and NIV join forces to fight zika, chikungunya & dengue")
Lupin founder Dr Desh Bandhu Gupta passes away
Dr Gupta, a doyen of Indian pharmaceutical industry, was 79 years old
 "Lupin founder Dr Desh Bandhu Gupta passes away")
NABCB selects TUV SUD to certify packaging materials for medicinal products
TUV SUD to certify makers of primary packaging materials for pharmaceuticals & medical devices
 "NABCB selects TUV SUD to certify packaging materials for medicinal products")
Jubilant Life ties up with Dutch firm Barentz for food & nutrition market
Through this collaboration Jubilant plans to offer nutrient premixes & blends to its customers
 "Jubilant Life ties up with Dutch firm Barentz for food & nutrition market")
